TP53 and gastric cancer: Notably, GC associated with diabetes often exhibits resistance to chemotherapy drugs, there is a study reported that the expression of NAMPT, SIRT1, p53, P-gp and Topo II α is higher in patients with both diabetes and GC, and the survival time is reduced.